A comprehensive study analyzed the efficacy of various therapeutics for ME/CFS and Long COVID across thousands of patients
Liver health support Lipo-C was originally developed to support liver function, and this remains one of its most well-documented benefits
BioMedWire Editorial Coverage: Obesity and type 2 diabetes mellitus (T2DM) rank among the most urgent and costly healthcare problems facing the world today, contributing to surging rates of cardiovascular disease, fatty liver disease, kidney complications and ballooning healthcare expenses
Fifth, due to lack of reported data, we could not analyze the dietary patterns, medication usage, gut microbiome profiles, L-carnitine bioavailability, or skeletal muscle carnitine content of the patients included in this meta-analysis, which may have had differential effects on the metabolism of L-carnitine
Neonatal Screen
20 ADMA is an endogenous nitric oxide synthase (NOS) inhibitor that can significantly reduce the synthesis of vasodilator NO, leading to the development of cardiovascular disease